QuidelOrtho Corporation

NASDAQ: QDEL
$40.82
+$0.42 (+1.0%)
Closing price April 24, 2024
QuidelOrtho Corporation specializes in diagnostic testing solutions across various healthcare settings. With a focus on improving patient care, the company offers a wide range of products including clinical chemistry and immunoassay instruments, tests for disease detection and monitoring, blood typing and donor screening tools for transfusions, and rapid tests for point-of-care use. Their molecular diagnostics unit advances infectious disease diagnostics through sophisticated systems. Serving a global market, QuidelOrtho reaches customers directly and via distributors, catering to hospitals, labs, clinics, and even individual use, all from their San Diego base since 1979.
Monday's top analyst upgrades and downgrades included Coca-Cola, Datadog, Domino’s Pizza, Enphase Energy, Harley-Davidson, Johnson & Johnson, Liberty Global, Microsoft, Nasdaq, Nike, Tesla and...
Wednesday's top analyst upgrades and downgrades included Bloomin' Brands, ChargePoint, Clorox, Cloudflare, Intel, Novavax, Owens Corning, Palo Alto Networks and PPL.
Tuesday’s top analyst upgrades and downgrades included Bilibili, Carvana, Crocs, GameStop, Goldman Sachs, Nike, Sarepta Therapeutics, Vir Biotechnology and Weber.
Friday's top analyst upgrades and downgrades included Biogen, CME, Dropbox, DocuSign, Nvidia, Ping Identity, Signet Jewelers and Tilray.
Friday's top analyst upgrades and downgrades included AvalonBay Communities, Bristol-Myers Squibb, Carrier, Comcast, CyrusOne, DraftKings, Nvidia and Textron.
Friday's top analyst upgrades and downgrades included Adobe, Ford, Goldman Sachs, Intel, Microsoft, Salesforce.com, Seagate Technology, Snowflake, Targa Resources and Walt Disney.